Most clinical reports take the position of drugs modulating by means of NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is obvious at reduced doses, and with increasing doses, it mimics psychotomimetic action and finally brings about anesthesia in increased doses.[four]For anyon